| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |